Skip to Main Content

Paper Details

Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
Clin Cancer Res
19
2019
6-Diazo-5-Oxo-L-Norleucine, 6-diazo-5-oxo-L-norleucine, AT, AT/, AT/RT, AT/RT cell lines, Atypical, Atypical Teratoid/Rhabdoid Tumors, Atypical teratoid/rhabdoid tumors, DON, GSH, Glutamine, High, MYC, MYC AT, MYC cell lines, MYC proto-oncogene, RT, carboplatin, cell models, glutamine, glutathione, high, infantile, infantile brain tumors, mouse, patient, patient-derived AT/RT cell lines
Author NameAffiliation
Brad PooreJohns Hopkins University
Brad PooreSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Brent A OrrSt. Jude Children's Research Hospital
Charles G EberhartJohns Hopkins University
Charles G EberhartJohns Hopkins University
Eric H RaabeJohns Hopkins University
Eric H RaabeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Eric H RaabeJohns Hopkins University
Jeffrey A RubensJohns Hopkins University
Jeffrey A RubensSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
  • 1 - 10

Datasets

Release 1.2